FUSION I ASSESSES SAFETY AND TOLERABILITY OF TWO DOSES OF NATRECOR (NESIRITIDE) ADMINISTERED TO PATIENTS WITH WORSENING CONGESTIVE (DECOMPENSATED) HEART FAILURE WHO ARE CONCURRENTLY RECEIVING THEIR USUAL CARDIAC MEDICATIONS AND ARE AT HIGH RISK FOR HOSPITALIZATION.: